DVA's first-quarter 2026 results benefit from expanding margins and steady dialysis demand across its broad clinic network.
DaVita HealthCare (DVA) came out with quarterly earnings of $2.87 per share, beating the Zacks Consensus Estimate of $2.41 per share. This compares to earnings of $2 per share a year ago.
DaVita on Tuesday raised its forecast for annual adjusted profit after beating Wall Street estimates for first-quarter results, betting on steady demand for its kidney dialysis services.
DaVita HealthCare (DVA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the latest trading session, DaVita HealthCare (DVA) closed at $151.99, marking a +1.28% move from the previous day.
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $152.42, denoting a +1.68% move from the preceding trading day.
DaVita HealthCare (DVA) closed the most recent trading day at $144.57, moving 3.27% from the previous trading session.
DaVita HealthCare (DVA) closed the most recent trading day at $150.68, moving +1.51% from the previous trading session.
DVA rides on EPS growth and early IKC profitability, but flat treatment volumes and reimbursement risks raise questions about sustaining momentum.
DaVita HealthCare (DVA) closed at $145.58 in the latest trading session, marking a -3.17% move from the prior day.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
In the most recent trading session, DaVita HealthCare (DVA) closed at $152.37, indicating a -1.33% shift from the previous trading day.